A New Abdomen Closure Technology Based on Component Separation: a Prospective Randomized Controlled Trial

NCT ID: NCT03111134

Last Updated: 2017-04-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

220 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-05-01

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

At present, open-type abdominal surgery is routine access into the abdomen. Median incision is the common choice with open-type abdominal surgery. Layered abdomen-closing is often used at the end-time of the surgery. There are some common postoperative complications, such as incision pain, surgical site infection, surgical incision dehiscence and incisional hernia. The key to reduce the incidence of postoperative complications depends on safe and reliable technology of abdomen-closing.

It's usually difficult to close the abdomen after the incisional hernia surgery, and the recurrence of incisional hernia is high. But the recurrence fell off observably when component separation technology was applied to abdomen-closing of incisional hernia.

Based on this, we hypothesis that modified-CST applied to abdomen-closing in routine abdominal surgery may improve the quality of wound-healing.

In this prospective single-blind randomized controlled trial, traditional abdomen-closing technology and modified-CST will be used to gastric cancer surgery, and the quality of wound-healing will be evaluated to confirm which kind of abdomen-closing technology better.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fascial Closure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Routine Abdominal Closure

Group Type NO_INTERVENTION

No interventions assigned to this group

New Abdominal Closure

modified component separation technique is used to abdomen closing.

Group Type EXPERIMENTAL

modified component separation technique

Intervention Type PROCEDURE

a new abdomen closure technique based on component separation technique

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

modified component separation technique

a new abdomen closure technique based on component separation technique

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult patients \>18 years of age
* undergoing gastric cancer surgery
* undergoing abdominal surgery first time
* median upper abdominal incision applied (length of incision \> 5cm)
* randomly select abdominal closure technique agreed by patients and family members

Exclusion Criteria

* women who pregnant
* coagulation disorders
* undergoing immunological therapy
* undergoing chemothearphy within 2 weeks before the surgery
* undergoing Abdominal radiotherapy within 8 weeks before the surgery
* spirit disease patients
* the expecting life span less than 48 hours
* no guarantees to follow-up for 3 years
* patients with poor compliance
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Xijing Hospital of Digestive Diseases

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Xiaonan Liu

associate professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Xiaonan Liu, Ph.D

Role: STUDY_CHAIR

Xijing Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Xijing Hospital

Xi’an, Shanxi, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Xiaonan Liu, Ph.D

Role: CONTACT

86-029-84771533

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Xiaonan Liu, Ph.D

Role: primary

+86 29 84771533

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CST001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Management of Burst Abdomen
NCT07229703 COMPLETED